Future Fund LLC Has $4.23 Million Position in HealthEquity, Inc. $HQY

Future Fund LLC lifted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 14.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 50,580 shares of the company’s stock after buying an additional 6,263 shares during the period. HealthEquity comprises 1.5% of Future Fund LLC’s portfolio, making the stock its 12th biggest holding. Future Fund LLC owned approximately 0.06% of HealthEquity worth $4,227,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in HQY. Acumen Wealth Advisors LLC bought a new stake in shares of HealthEquity in the 4th quarter worth approximately $27,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd increased its position in shares of HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after purchasing an additional 293 shares during the period. Leonteq Securities AG increased its position in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after purchasing an additional 235 shares during the period. Finally, Torren Management LLC acquired a new position in shares of HealthEquity in the fourth quarter valued at $40,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at HealthEquity

In related news, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the sale, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This trade represents a 7.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 2,354 shares of the business’s stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $95.00, for a total value of $223,630.00. Following the sale, the executive vice president directly owned 52,244 shares of the company’s stock, valued at $4,963,180. This represents a 4.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 17,905 shares of company stock worth $1,651,280 over the last 90 days. 1.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on HQY shares. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Citizens Jmp lifted their price objective on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. Wall Street Zen lowered HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, July 4th. Barrington Research reissued an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd. Finally, Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a report on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and an average target price of $110.57.

HealthEquity Stock Down 1.0%

Shares of HQY opened at $97.67 on Friday. The company has a market capitalization of $8.17 billion, a P/E ratio of 36.58, a PEG ratio of 1.66 and a beta of 0.21. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $105.96. The business’s 50 day simple moving average is $88.76 and its 200-day simple moving average is $84.78. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. The company’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, sell-side analysts predict that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.